A novel angiogenesis-related scoring model predicts prognosis risk and treatment responsiveness in diffuse large B-cell lymphoma
- 4 July 2023
- journal article
- research article
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 23 (7) , 3781-3797
Abstract
No abstract availableKeywords
Funding Information
- 1+X program for clinical competency enhancement–improvement of MDT project, The Second Affiliated Hospital of Dalian Medical University (2022MDTZY02)
- National Natural Science Foundation of China (81800203)
- Doctoral Startup Scientific Research Foundation of Liaoning Province (20180540088)
This publication has 62 references indexed in Scilit:
- Tumor microenvironment (TME)-driven immune suppression in B cell malignancyBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2016
- Tumor microenvironment: Sanctuary of the devilCancer Letters, 2015
- BRCC3 acts as a prognostic marker in nasopharyngeal carcinoma patients treated with radiotherapy and mediates radiation resistance in vitroRadiation Oncology, 2015
- Microvascular density, CD68 and tryptase expression in human Diffuse Large B-Cell LymphomaLeukemia Research, 2014
- Microenvironmental regulation of tumor progression and metastasisNature Medicine, 2013
- The Role of Angiogenesis in Human Non-Hodgkin LymphomasNeoplasia, 2013
- High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapyHaematologica, 2011
- Stromal Gene Signatures in Large-B-Cell LymphomasNew England Journal of Medicine, 2008
- Prognostic significance of activated cytotoxic T-lymphocytes in primary nodal diffuse large B-cell lymphomasLeukemia, 2003
- Establishment and characterization of an Epstein-Barr virus negative B-cell lymphoma cell line and successful heterotransplantation.The Tohoku Journal of Experimental Medicine, 1988